Latest Breaking News On - Annika kurreck - Page 1 : comparemela.com

Patients with metastatic disease experienced a progression-free survival benefit on maintenance therapy but worse toxicity and no overall survival advantage compared with those on active monitoring.

United kingdomAnnika kurreckRichard adamsNational institute for health researchCancer research united kingdomUniversity medicine berlinBristol myers squibbCardiff universityMurtaza kasiWeill cornellClinical oncologyCharity university medicine berlinNational institutePublished novemberColorectal cancerColon cancer